David Pejoski - University of Geneva - Maître Assistant / Postdoctoral Researcher

David Pejoski

University of Geneva

Maître Assistant / Postdoctoral Researcher

Geneva | Switzerland

Main Specialties: Biology

Additional Specialties: immunology

ORCID logohttps://orcid.org/0000-0001-5010-0550

David Pejoski - University of Geneva - Maître Assistant / Postdoctoral Researcher

David Pejoski

Introduction

Primary Affiliation: University of Geneva - Geneva , Switzerland

Specialties:

Additional Specialties:

Research Interests:

Education

Mar 2006 - May 2011
University of Melbourne
Ph.D.

Experience

Dec 2015
University of Geneva
Maître Assistant / Postdoctoral Researcher
Department of Pathology and Immunology, W.H.O. Centre for Vaccinology

Publications

8Publications

379Reads

17Profile Views

Site-Specific DC Surface Signatures Influence CD4 T Cell Co-stimulation and Lung-Homing.

Front Immunol 2019 18;10:1650. Epub 2019 Jul 18.

Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.01650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668556PMC
July 2019
12 Reads

A computational approach for phenotypic comparisons of cell populations in high-dimensional cytometry data.

Methods 2018 01 14;132:66-75. Epub 2017 Sep 14.

CEA - Université Paris Sud 11 - INSERM U1184, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Infrastructure, 92265 Fontenay-aux-Roses, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2017.09.005DOI Listing
January 2018
67 Reads
3.645 Impact Factor

Identification of Vaccine-Altered Circulating B Cell Phenotypes Using Mass Cytometry and a Two-Step Clustering Analysis.

J Immunol 2016 06 2;196(11):4814-31. Epub 2016 May 2.

University of Paris South, U1184, 92265 Fontenay-aux-Roses, France; French Atomic Energy and Alternative Energies Commission, Organization for the Direction of Fundamental Research/Institute of Emerging Diseases and Innovative Therapies, U1184, Immunology of Viral Infections and Autoimmune Diseases, Infectious Disease Models and Innovative Therapies Infrastructure, 92265 Fontenay-aux-Roses, France; INSERM, U1184, 94276 Le Kremlin-Bicêtre, France; Vaccine Research Institute, Henri Mondor Hospital, 94010 Créteil, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1502005DOI Listing
June 2016
126 Reads
4.922 Impact Factor

Soluble proteins induce strong CD8+ T cell and antibody responses through electrostatic association with simple cationic or anionic lipopeptides that target TLR2.

J Immunol 2011 Aug 8;187(4):1692-701. Epub 2011 Jul 8.

Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1100486DOI Listing
August 2011
15 Reads
4.922 Impact Factor

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.

Immunol Cell Biol 2010 Jul 23;88(5):605-11. Epub 2010 Feb 23.

Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/icb.2010.15DOI Listing
July 2010
22 Reads
4.147 Impact Factor

Top co-authors

Roger Le Grand
Roger Le Grand

Université Paris-Sud

3
Anne-Sophie Beignon
Anne-Sophie Beignon

National Institute for Biological Standards and Control

3
Antonio Cosma
Antonio Cosma

Institute of Molecular Virology

2
David C Jackson
David C Jackson

The University of Melbourne

2
Guillaume Gautreau
Guillaume Gautreau

CEA - Université Paris Sud 11 - INSERM U1184

2
Weiguang Zeng
Weiguang Zeng

The University of Melbourne

2
Pascal Clayette
Pascal Clayette

Université Paris-Sud

1
Nathalie Dereuddre-Bosquet
Nathalie Dereuddre-Bosquet

France; Vaccine Research Institute (VRI)

1